All these differences were reflected in a principal components analysis where CAR-T cells from AML patients clustered together and close to those from senior healthy donors, being separated from CAR-T cells from adult healthy donors in both CD4+ and CD8+ CAR-T cell subsets (Figure 4A). This evidence concerns the gene CD4 and acute myeloid leukemia.